Jaguar Health (JAGX) said Wednesday that it has entered into securities purchase agreements to issue up to nearly $3.5 million in convertible promissory notes to Chief Executive Lisa Conte, three board members, seven other senior executives, and selected investors.
The notes, which have a 3-month maturity and 6% annual interest, can be converted into common stock at the investors' option, the company said. In addition, the investors will receive unregistered warrants that can be exercised immediately and will expire in five years, or in the event of a major transaction or liquidation event, the company added.
The proceeds from this private placement, set to close around Thursday, will be used for working capital and other general corporate purposes, Jaguar Health said.
Shares of Jaguar Health fell 6.7% in recent trading.
Price: 5.05, Change: -0.36, Percent Change: -6.65
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。